This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Agilent officials believe that the comprehensive asset-management programs that it and a couple of key competitors have launched over the past couple of years are winning over a cost-conscious pharmaceutical industry, and will eventually be used by a growing number of large and mid-tier firms.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.